Moderna, Inc. - Laporan Laba Rugi (TTM)

Moderna, Inc.
CH ˙ BRSE ˙ US60770K1079
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Moderna, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 246 803 2,732 7,019 11,831 18,471 22,600 22,995 21,390 19,263 15,059 10,654 9,121 6,848 5,153 5,050 5,081 3,236 3,177 3,078
Change (%) 226.35 240.22 156.92 68.56 56.12 22.35 1.75 -6.98 -9.94 -21.82 -29.25 -14.39 -24.92 -24.75 -2.00 0.61 -36.31 -1.82 -3.12
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 729 1,378 1,857 2,876 3,775 4,608 5,585 6,505 7,182 8,711 9,063 8,851 10,332 9,538 8,774 8,231 6,481 6,007 5,794 5,277
Change (%) 89.04 34.76 54.87 31.26 22.07 21.20 16.47 10.41 21.29 4.04 -2.34 16.73 -7.68 -8.01 -6.19 -21.26 -7.31 -3.55 -8.92
% of Revenue 296.26 171.61 67.97 40.97 31.91 24.95 24.71 28.29 33.58 45.22 60.18 83.08 113.28 139.28 170.27 162.99 127.55 185.63 182.37 171.44
Gross Operating Profit -483 -575 875 4,143 8,056 13,863 17,015 16,490 14,208 10,552 5,996 1,803 -1,211 -2,690 -3,621 -3,181 -1,400 -2,771 -2,617 -2,199
Change (%) 19.07 -252.17 373.49 94.45 72.08 22.74 -3.09 -13.84 -25.73 -43.18 -69.93 -167.17 122.13 34.61 -12.15 -55.99 97.93 -5.56 -15.97
% of Revenue -196.26 -71.61 32.03 59.03 68.09 75.05 75.29 71.71 66.42 54.78 39.82 16.92 -13.28 -39.28 -70.27 -62.99 -27.55 -85.63 -82.37 -71.44
SG&A 135 188 241 325 445 567 758 848 958 1,132 1,169 1,290 1,454 1,549 1,518 1,454 1,293 1,174 1,112 1,074
Change (%) 39.56 28.19 34.85 36.92 27.42 33.69 11.87 12.97 18.16 3.27 10.35 12.71 6.53 -2.00 -4.22 -11.07 -9.20 -5.28 -3.42
% of Revenue 54.75 23.41 8.82 4.63 3.76 3.07 3.35 3.69 4.48 5.88 7.76 12.11 15.94 22.62 29.46 28.79 25.45 36.28 35.00 34.89
R&D
Change (%)
% of Revenue
OpEx 864 1,566 2,098 3,201 4,220 5,175 6,343 7,353 8,140 9,843 10,232 10,141 11,786 11,087 10,292 9,685 7,774 7,181 6,906 6,351
Change (%) 81.32 33.97 52.57 31.83 22.63 22.57 15.92 10.70 20.92 3.95 -0.89 16.22 -5.93 -7.17 -5.90 -19.73 -7.63 -3.83 -8.04
% of Revenue 351.00 195.02 76.79 45.60 35.67 28.02 28.07 31.98 38.06 51.10 67.95 95.18 129.22 161.90 199.73 191.78 153.00 221.91 217.37 206.34
Operating Income -618 -763 634 3,818 7,611 13,296 16,257 15,642 13,250 9,420 4,827 513 -2,665 -4,239 -5,139 -4,635 -2,693 -3,945 -3,729 -3,273
Change (%) 23.54 -183.09 502.21 99.35 74.69 22.27 -3.78 -15.29 -28.91 -48.76 -89.37 -619.49 59.06 21.23 -9.81 -41.90 46.49 -5.48 -12.23
% of Revenue -251.00 -95.02 23.21 54.40 64.33 71.98 71.93 68.02 61.94 48.90 32.05 4.82 -29.22 -61.90 -99.73 -91.78 -53.00 -121.91 -117.37 -106.34
Interest Expense -8 -10 -12 -14 -16 -17 -20 -20 -24 -29 -32 -40 -42 -38 -35 -28 -24 -24 -19 -14
Change (%) 30.60 20.00 16.67 14.29 6.25 17.65 -0.00 20.00 20.83 10.34 25.00 5.00 -9.52 -7.89 -20.00 -14.29 -0.00 -20.83 -26.32
% of Revenue -3.11 -1.25 -0.44 -0.20 -0.14 -0.09 -0.09 -0.09 -0.11 -0.15 -0.21 -0.38 -0.46 -0.55 -0.68 -0.55 -0.47 -0.74 -0.60 -0.45
Net Income -597 -747 598 3,495 7,061 12,202 14,638 14,055 11,765 8,362 4,784 1,207 -3,466 -4,714 -5,968 -5,867 -2,224 -3,561 -3,357 -2,903
Change (%) 25.06 -180.05 484.45 102.03 72.81 19.96 -3.98 -16.29 -28.92 -42.79 -74.77 -387.16 36.01 26.60 -1.69 -62.09 60.12 -5.73 -13.52
% of Revenue -242.75 -93.03 21.89 49.79 59.68 66.06 64.77 61.12 55.00 43.41 31.77 11.33 -38.00 -68.84 -115.82 -116.18 -43.77 -110.04 -105.67 -94.31

Source: Capital IQ

Other Listings
MX:MRNA
PE:MRNA
BG:0QF
GB:0A45 US$ 24.70
IT:1MRNA € 21.30
US:MRNA US$ 25.14
DE:0QF € 21.42
GB:0QFD
AT:MRNA
KZ:MRNA_KZ
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista